Hence, abrogation of LFPRLR synthesis in 16-week-old TCL1-tg-mice specifically impacts pre-malignant B cells and reduces the major indicators of B-cell lymphoma risk specific to this age group. Here, TG is linked to B-cell non-Hodgkin lymphoma.